Rentschler Biopharma SE: Rentschler Biopharma and ATUM announce Leap-In Transposase® licensing agreement for development of robust manufacturing processes for complex therapeutic proteins Written by Petra Hegmann on 14th October 2020. Posted in Client News. Previous Next